MTOR and lung adenocarcinoma: Due to the increased protein expression of the mTOR signaling pathway, we conducted an additional prognostic analysis (data set GSE13213), and we found a significant correlation between mTOR (mRNA) overexpression with low overall survival rates in patients with lung adenocarcinoma (HR = 1.16, 95%, p = 0.04).